Kenji Harada
Director
Pharmaceuticals
Complexa
Philippines
Biography
Dr. Harada, Ph.D. has more than 20 years of experience in evaluating medical drug candidates, scientific technology platforms and intellectual property portfolios. In 2004, he joined JAFCO, the largest venture capital firm in Japan, working for the life science investment group as a group leader. In this role, he evaluates US or Japan-based biotech companies for potential investment opportunities, several of which have successfully gone on to become public companies or the subject of significant acquisitions. Prior to JAFCO, Dr. Harada held positions of increasing responsibility within the medical drug and devices division of Toray Industries, Inc., a leading Japanese chemical and fiber company, most recently as manager for collaborative research agreements with a number of leading Japanese academic institutes and biotechnology companies. In addition to his board position at Complexa, Dr. Harada also served on the board of TRACON Pharmaceuticals and Eleven Biotherapeutics. He is an immunologist by training, earning his PhD in pharmacology at the University of Tokyo.
Research Interest
Pharmaceuticals and life sciences
